Explore how diabetes medicines work to regulate blood sugar levels and support overall health in simple terms.
How Diabetes Medicines Work in the Body
Blood sugar powers many functions inside our bodies. Glucose supplies energy to cells throughout the body. For people who need help controlling blood sugar, Diabetes medicines can help the body manage glucose levels. However, glucose needs help entering many cells. That help mainly comes from a hormone called insulin.
Diabetes changes this normal process in different ways. Some people produce too little insulin. Others cannot use insulin effectively. Therefore, glucose can remain in the bloodstream. Over time, high glucose can damage blood vessels and organs. That is where diabetes medicines become important. Different medicines target different parts of glucose control. Some reduce glucose production inside the liver. Others increase insulin action. Some remove extra glucose through urine. This guide explains those medicines in simple language. It also explains what happens inside the body. The goal is understanding, not self-treatment. Diabetes medicines should always be taken as directed by a healthcare professional.
Key Takeaways
- Metformin mainly reduces glucose production by the liver.
- Insulin replaces or supplements missing insulin.
- GLP-1 medicines improve glucose control and affect appetite.
- SGLT2 inhibitors remove more glucose through urine.
- DPP-4 inhibitors enhance the effects of incretin hormones.
- Sulfonylureas stimulate insulin release from pancreatic cells.
- Some medicines can also benefit heart or kidney health.
- Each medicine has specific risks and precautions.
- Treatment choices should be individualized for each person.
These medicines do not all work in the same way. Therefore, understanding their actions helps explain treatment choices. It also helps students understand modern pharmacology. Above all, the choice of medicine depends on the person.
What Happens to Blood Sugar in the Body?
After eating, carbohydrates are broken down into glucose, which then enters the bloodstream. As a result, blood glucose levels normally rise after meals. In response, the pancreas releases insulin. Insulin acts as a biological signal that tells the body’s cells to take up glucose. For example, muscle cells use glucose for energy or store it for later use. Similarly, fat cells can absorb glucose and store energy.
At the same time, insulin affects the liver differently. Rather than promoting glucose uptake, it reduces the liver’s production and release of glucose. Consequently, this action helps prevent blood glucose levels from becoming excessively high. In contrast, the hormone glucagon increases blood glucose by signaling the liver to release stored glucose. However, people with diabetes may experience problems with either insulin production, insulin action, or both. Therefore, glucose control becomes more difficult, and blood glucose levels may remain elevated.
Type 1 Diabetes and Insulin
Type 1 diabetes occurs when the immune system mistakenly attacks and destroys the beta cells in the pancreas. These cells normally make insulin. As a result, people with type 1 diabetes must use insulin therapy to control their blood glucose levels.
Insulin delivery is especially important because insulin cannot usually be taken as a regular pill. For a simple, student-friendly explanation of newer insulin-delivery methods, including oral insulin delivery, see ENTECH’s article. This topic helps explain why researchers continue to develop easier and more effective ways to deliver insulin.
Type 2 Diabetes and Insulin Resistance
Type 2 diabetes usually develops differently. First, the body’s cells become less responsive to insulin. This problem is called insulin resistance.
At first, the pancreas may produce more insulin to compensate. As a result, blood glucose levels may remain close to normal for some time. However, beta cells can weaken over the years and produce less insulin. Consequently, blood glucose levels may gradually increase. For this reason, diabetes medicines can work in several ways. Some help the body respond better to insulin, while others help the pancreas release more insulin. In addition, certain medicines reduce the amount of glucose made by the liver or absorbed from food. Together, these treatments help control blood glucose levels.
How Diabetes Medicines Work
Diabetes medicines work on different processes in the body. To understand this, think of blood glucose control as a series of checkpoints. First, the liver makes and releases glucose. Next, the pancreas produces hormones that help control blood glucose. The kidneys filter glucose from the blood, while the muscles use glucose for energy.
Because each medicine class acts on one or more of these checkpoints, the medicines can have different effects. For example, some reduce glucose production by the liver, whereas others help the body use insulin more effectively or remove extra glucose through the kidneys. Therefore, healthcare professionals choose medications based on how a person’s body handles glucose.
Diabetes Medicines: Main Drug Classes
| Medicine class | What it does | Example | Safety note |
|---|---|---|---|
| Biguanides | Reduces liver glucose production | Metformin | Kidney function matters |
| Insulin | Replaces or supplements insulin | Insulin glargine | Can cause hypoglycemia |
| GLP-1 receptor agonists | Increase glucose-dependent insulin effects | Semaglutide | Gastrointestinal effects can occur |
| SGLT2 inhibitors | Increase glucose loss through urine | Empagliflozin | Dehydration and infections can occur |
| DPP-4 inhibitors | Prolong incretin hormone activity | Sitagliptin | Usually low hypoglycemia risk alone |
| Sulfonylureas | Stimulate pancreatic insulin release | Glimepiride | Hypoglycemia can occur |
| Thiazolidinediones | Improve insulin sensitivity | Pioglitazone | Weight gain and fluid retention can occur |
Metformin: Reducing Glucose Production
Metformin is an important medicine for managing type 2 diabetes. It is widely used because it mainly works in the liver.
Normally, the liver makes and releases glucose between meals to keep blood glucose levels steady. However, in people with type 2 diabetes, the liver may produce too much glucose. Metformin helps reduce this extra glucose production. It also helps the body respond better to insulin. As a result, blood glucose levels may decrease.
Kidney function is also important when taking metformin. Therefore, healthcare professionals usually check kidney health before and during treatment. If kidney function changes, they may need to adjust the dose or choose a different medicine.
Insulin: Replacing a Missing Hormone
Insulin differs from most other diabetes medicines because it directly replaces a hormone that the body needs. This hormone helps glucose move from the blood into many cells, where it can be used for energy. There are several types of insulin, and each one works for a different length of time. For example, basal insulin provides a steady supply of insulin throughout the day and night. In contrast, mealtime insulin helps control the rise in blood glucose that occurs after eating.
Insulin is essential for people with type 1 diabetes because their bodies produce little or no insulin. However, some people with type 2 diabetes may also need insulin over time. In addition, insulin may be used when blood glucose levels are very high.
The main safety concern is hypoglycemia, which means that blood glucose levels become too low. Warning signs may include sweating, shaking, confusion, and weakness. Therefore, people using insulin should learn how to recognize and treat low blood glucose. Therefore, insulin doses require careful adjustment. Food, activity, illness, and other medicines matter.
GLP-1 Medicines: Working With Gut Hormones
GLP-1 medicines work through the incretin pathway. GLP-1 is a natural hormone that helps control blood glucose after eating. These medicines help the pancreas release more insulin when blood glucose levels are high. They also reduce the release of glucagon, a hormone that raises blood glucose. In addition, some GLP-1 medicines slow the movement of food through the stomach.
As a result, these medicines can help lower blood glucose levels. They may also reduce appetite, so some GLP-1 medicines can support weight management. For a more detailed explanation, see ENTECH’s article on GLP-1 receptor agonist drugs. However, GLP-1 medicines may cause side effects. The most common include nausea and vomiting. Some people may also experience diarrhea or constipation. Because each product is different, specific warnings and precautions may vary.
SGLT2 Inhibitors: Sending Glucose Into Urine
However, like all medicines, GLP-1 medicines can cause side effects. For example, the most common side effects are nausea and vomiting. In addition, some people may have diarrhea or constipation. Since each GLP-1 medicine is different, the warnings and safety instructions may also vary. Therefore, patients should follow their healthcare professional’s advice and read the information provided with their medicine.
DPP-4 Inhibitors: Protecting Incretin Signals
DPP-4 inhibitors work through a different incretin-based pathway. Normally, an enzyme called DPP-4 breaks down incretin hormones. These hormones help the body control blood glucose after eating. By blocking DPP-4, these medicines allow incretin hormones to remain active for longer. As a result, the pancreas can release more insulin when blood glucose levels are high. They also help reduce the release of glucagon, which can raise blood glucose.
When used alone, DPP-4 inhibitors usually have a low risk of causing hypoglycaemia, or low blood glucose. In addition, they are generally weight-neutral, meaning they do not typically cause weight gain or loss. Examples include sitagliptin and linagliptin. However, each medicine has different safety warnings and precautions. Therefore, healthcare professionals choose treatment based on each patient’s needs and health condition.
Sulfonylureas: Stimulating Insulin Release
Sulfonylureas work by stimulating the beta cells in the pancreas. As a result, these cells release more insulin, which can effectively lower blood glucose levels. Common examples include glimepiride and gliclazide. However, these medicines can increase insulin release even when blood glucose levels are not high. Therefore, they may cause hypoglycaemia, or blood glucose that is too low.
In addition, some people may gain weight while taking sulfonylureas. Because of these risks, healthcare professionals carefully choose the medicine and dose for each patient.
Thiazolidinediones: Improving Insulin Sensitivity
Thiazolidinediones help the body respond better to insulin. They do this by activating a cell receptor called PPAR-gamma, which helps control the activity of certain genes. As a result, tissues such as muscle and fat can use insulin more effectively. Consequently, blood glucose levels may decrease.
Pioglitazone is a common example of this medicine. However, it may cause weight gain and fluid retention, leading to extra fluid buildup in the body. Therefore, healthcare professionals carefully consider the risk of heart failure before prescribing it. Overall, treatment decisions should balance the possible benefits and risks.
How Doctors Choose Diabetes Medicines
There is no single diabetes medicine that works best for everyone. Diabetes can affect people in different ways, and a person’s treatment needs may change over time. Therefore, healthcare professionals consider several factors before choosing a medicine. For example, they review blood glucose and A1C levels, as well as the person’s weight and kidney function. They may also consider other health conditions.
In addition, heart disease can affect medication choices. Similarly, heart failure may make some medicines more suitable than others. Kidney disease can also change the preferred treatment options. As a result, healthcare professionals select medicines based on each person’s health needs and treatment goals.
Diabetes Medicines and Heart Health
Some diabetes medicines may also help protect the heart. For example, GLP-1 receptor agonists can provide heart-related benefits for certain patients. Similarly, SGLT2 inhibitors may help reduce some heart risks.
However, these benefits can vary depending on the specific medicine and the patient’s health. Therefore, it is important to avoid making broad claims. Healthcare professionals should choose treatment based on each person’s medical needs and risk factors.
Diabetes Medicines and Kidney Health
Kidney health is another important factor when choosing diabetes treatment. For example, SGLT2 inhibitors may help slow the worsening of kidney disease. In addition, their kidney benefits may occur even beyond their ability to lower blood glucose.
Some GLP-1 medicines may also provide kidney-related benefits. However, the research results differ from one medicine to another. Therefore, healthcare professionals carefully check kidney function before choosing a treatment. As a result, the medicine should be tailored to the patient’s health, kidney function, and overall medical needs.
Diabetes Medicines and Body Weight
Body weight can also affect the choice of diabetes medicine. Some medicines may help with weight loss, while others may cause weight gain.
For example, GLP-1 medicines can reduce appetite in many people. Similarly, SGLT2 inhibitors may lead to modest weight loss. Metformin is usually weight-neutral, meaning it does not usually cause weight gain or loss, and it may sometimes support slight weight loss. In contrast, insulin and sulfonylureas may cause weight gain. Therefore, healthcare professionals consider a person’s weight goals when planning treatment.
Diabetes Medicines and Hypoglycemia
Hypoglycemia occurs when blood glucose levels become too low. As a result, a person may experience sweating, shaking, hunger, or confusion. In severe cases, hypoglycemia can lead to seizures or loss of consciousness.
Insulin can cause hypoglycemia, and sulfonylureas can also increase this risk. In comparison, other types of diabetes medicines usually have a lower risk when used alone. However, combining medicines can change the risk. Therefore, healthcare professionals should review treatment plans regularly.
Patients should learn to recognise the warning signs of hypoglycaemia. They should also know how to follow their prescribed rescue plan if they experience low blood glucose.
Using Diabetes Medicines Safely
Diabetes medicines work best when they are used correctly. However, safe treatment involves more than simply taking tablets. For example, food choices, physical activity, illness, and other medicines can affect blood glucose levels. In addition, kidney and liver function can change how the body processes medicines. Therefore, regular monitoring is an important part of diabetes care. It helps healthcare professionals check whether treatment is working safely and make changes when needed.
Five Practical Safety Rules
- Take medicines exactly as prescribed.
- Do not change doses without advice.
- Track glucose when advised by clinicians.
- Report troublesome side effects early.
- Keep regular diabetes follow-up appointments.
These steps can help prevent many treatment problems. In addition, they can support better long-term blood glucose control.
For this reason, never share prescription diabetes medicines with anyone else. Also, avoid buying medicines from unreliable sources, as unverified products may contain incorrect ingredients or unsafe substances. Furthermore, blood glucose levels can change quickly during illness. Therefore, follow your healthcare team’s sick-day plan and contact them if your glucose levels are difficult to control.
Why Monitoring Matters
A medicine may not work the same way over time because diabetes can gradually change. Consequently, treatment may need to be adjusted.
For example, an A1C test shows a person’s average blood glucose level over the past two to three months. In contrast, home glucose checks provide information about blood glucose at a specific time. In addition, continuous glucose monitors show glucose patterns throughout the day and night. Together, these tools help healthcare professionals guide treatment and monitor progress. They can also help identify episodes of hypoglycemia (low blood glucose) and high blood glucose levels.
The Future of Diabetes Medicines
Diabetes treatment is developing quickly. As a result, new medicines are being designed to target different processes in the body. Researchers are also exploring better ways to deliver these medicines.
For example, combination treatments can act on multiple processes simultaneously. In addition, newer insulin technologies may improve blood glucose control. Cell-based treatments are also being studied as possible future options. However, promising early research must be supported by strong clinical evidence. A result seen in a laboratory does not always mean that a treatment will help people. Therefore, large clinical trials are needed to confirm a treatment’s safety and effectiveness.
Therefore, patients should use approved treatments appropriately. Research medicines belong within carefully monitored studies. The broader ENTECH diabetes-medicine guide discusses current treatments. It also explains emerging treatment approaches. Read the diabetes medicines overview for additional context.
Why Personalized Treatment Matters
Diabetes treatment is not based on one simple plan. Instead, each person has different health needs, risks, and treatment goals.
For example, one person may want to manage their weight, while another may need extra kidney protection. Similarly, someone else may prefer a simpler dosing schedule. In addition, the cost and availability of medicines can affect treatment choices. A person’s preferences also matter because they can influence whether the treatment is followed regularly.
Therefore, shared decision-making between the patient and healthcare professional is important. In short, diabetes medicines should fit the patient—not just the diagnosis.
Conclusion
Diabetes medicines act on different body processes. They may improve insulin action, increase insulin secretion, reduce hepatic glucose production, or increase glucose excretion in urine. Therefore, treatment varies by individual needs. Patients should follow medical advice and never change medicines without professional guidance.
Frequently Asked Questions About Diabetes Medicines
What are diabetes medicines?
Diabetes medicines help control blood glucose by acting on different processes in the body. For example, some medicines increase insulin release or help the body use insulin more effectively. In contrast, other medicines reduce glucose production or slow its absorption. As a result, each medicine class helps control blood glucose in a different way.
How does metformin work?
Metformin mainly reduces the amount of glucose produced by the liver. In addition, it helps the body respond more effectively to insulin. As a result, blood glucose levels can decrease.
How does insulin work?
Insulin replaces or supplements the insulin that the body cannot produce adequately. As a result, it helps glucose move from the bloodstream into many cells, where it can be used for energy. Therefore, insulin is essential for people with type 1 diabetes.
How do GLP-1 medicines work?
GLP-1 medicines mimic the action of incretin hormones. As a result, they increase insulin release when blood glucose levels are high. In addition, they reduce glucagon activity, which helps prevent blood glucose from rising. Some GLP-1 medicines also slow the movement of food through the stomach.
How do SGLT2 inhibitors work?
SGLT2 inhibitors reduce the kidneys’ reabsorption of glucose. As a result, more glucose leaves the body through urine, which helps lower blood glucose levels. In addition, this effect works largely independently of insulin.
References
- Davies, M. J., Aroda, V. R., Collins, B. S., et al. (2022). Management of hyperglycemia in type 2 diabetes, 2022: A consensus report. Diabetes Care, 45(11), 2753–2786. https://doi.org/10.2337/dci22-0034
- Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., et al. (2017). Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Frontiers in Endocrinology, 8, 6. https://doi.org/10.3389/fendo.2017.00006
- Author
- Latest Posts
Ramya Dobbala is a pharmacist and science communicator dedicated to bridging the gap between complex pharmaceutical research and public understanding. A 2024 B.Pharmacy graduate, Ramya has a strong foundational background in formulation science, having spearheaded research into the evaluation and formulation of anti-acne creams. Her work focused on optimizing topical delivery systems to enhance treatment efficacy and skin health.
Transitioning from the laboratory to the forefront of scientific discourse, she now leverages her technical expertise to translate intricate healthcare concepts into accessible, engaging content. As an author and communicator, Ramya is passionate about empowering audiences with evidence-based insights, particularly in the realms of dermatology and pharmaceutical innovation.
